Syringe sharing among people who inject drugs in Tijuana: before and after the Global Fund
##plugins.themes.bootstrap3.article.main##
Abstract
Introduction. Needle and syringe programs (NSP) reduce syringe sharing and HIV transmission among people who inject drugs (PWID). However, their effectiveness relies on sufficient individual and population level coverage. In Tijuana, Mexico, the Global Fund (GF) supported NSP during 10/2011-12/2013, but withdrew funds at the end of 2013 following Mexico’s re-classification as an upper-middle income country.
Objective. We tested the hypothesis of higher NSP access and lower receptive syringe sharing among PWID in Tijuana during the GF support period compared to pre-GF initiation and post-GF withdrawal.
Method. We used data from an ongoing cohort study of PWID in Tijuana (03/2011-10/2015) to implement a segmented regression analysis investigating changes in the self-reported probability of NSP access, reported difficulty in finding sterile syringes and receptive syringe sharing before GF initiation and after GF discontinuation.
Results. We found a large significant increase in the probability of NSP access (+.07) and decrease in receptive syringe sharing (-.23) right after GF initiation, which continued over the GF period. Subsequently, we found a significant decline in NSP access (-.05) and an increase in receptive syringe sharing (+.02) right after post-GF withdrawal, which continued thereafter.
Discussion and conclusion. We demonstrated significant temporal changes in NSP access and receptive syringe sharing among PWID in Tijuana after GF initiation and withdrawal consistent with our hypothesis. Coordinated efforts with local authorities are needed to sustain major coverage NSP in settings receiving GF or external aid to guarantee continuity of harm reduction services and prevent reinside in risk behaviors associated with HIV transmission.
References
Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., ... Hutchinson, S. J. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235-248. doi: 10.1093/ije/dyt243
Bridge, J., Hunter, B. M., Albers, E., Cook, C., Guarinieri, M., Lazarus, J. V., ... Wolfe, D. (2016). The global fund to fight AIDS, Tuberculosis and Malaria’s investments in harm reduction through the rounds-based funding model (2002-2014). International Journal of Drug Policy, 27, 132-137. doi: 10.1016/j.drugpo.2015.08.001
Cepeda, J. A., Burgos, J. L., Kahn, J. G., Padilla, R., Meza Martinez, P. E., Segovia, L. A., ... Martin, N. K. (2019). Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: A costing analysis. BMJ Open, 9(1), e026298. doi: 10.1136/bmjopen-2018-026298
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., ... Beyrer, C. (2016). Public health and international drug policy. The Lancet, 387(10026), 1427-1480. doi: 10.1016/S0140-6736(16)00619-X
Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., ... Carneiro, A. V. (2017). Effectiveness of needle and syringe Programmes in people who inject drugs–An overview of systematic reviews. BMC Public Health, 17(1), 309. doi: 10.1186/s12889-017-4210-2
Kelley, M. S., Murphy, S., & Lune, H. (2001). A cultural impact of needle exchange: The role of safer-injection mentors. Contemporary Drug Problems, 28(3), 485-506. doi: 10.1177/009145090102800308
Lopez Bernal, J., Cummins, S., & Gasparrini, A. (2017). Interrupted time series regression for the evaluation of public health interventions: A tutorial. International Journal of Epidemiology, 46(1), 348-355. doi: 10.1093/ije/dyw098
PI: Steffanie Strathdee. (2010-2020). Proyecto el Cuete phase IV: NIDA grant R01 DA0 19829.
Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., ... Hickman, M. (2017). Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database of Systematic Reviews, (9), CD012021. doi: 10.1002/14651858.CD012021.pub2
Robertson, A. M., Garfein, R. S., Wagner, K. D., Mehta, S. R., Magis-Rodriguez, C., Cuevas-Mota, J., ... Strathdee, S. A. (2014). Evaluating the impact of Mexico’s drug policy reforms on people who inject drugs in Tijuana, BC, Mexico, and San Diego, CA, United States: A binational mixed methods research agenda. Harm Reduction Journal, 11(1), 4. doi: 10.1186/1477-7517-11-4
Sawangjit, R., Khan, T. M., & Chaiyakunapruk, N. (2017). Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: A systematic review and meta-analysis. Addiction, 112(2), 236-247. doi: 10.1111/add.13593
Shaw, S. Y., Shah, L., Jolly, A. M., & Wylie, J. L. (2007). Determinants of injection drug user (IDU) syringe sharing: The relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada. Addiction, 102(10), 1626-1635. doi: 10.1111/j.1360-0443.2007.01940.x
Snead, J., Downing, M., Lorvick, J., Garcia, B., Thawley, R., Kegeles, S., & Edlin, B. R. (2003). Secondary syringe exchange among injection drug users. Journal of Urban Health, 80(2), 330-348. doi: 10.1093/jurban/jtg035
Strathdee, S. A., Lozada, R., Martinez, G., Vera, A., Rusch, M., Nguyen, L., ... Patterson, T. L. (2011). Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PLoS One, 6(4), e19048. doi: 10.1371/journal.pone.0019048
Strathdee, S. A., Lozada, R., Ojeda, V. D., Pollini, R. A., Brouwer, K. C., Vera, A., ... Patterson, T. L. (2008). Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PloS One, 3(7), e2690. doi: 10.1371/journal.pone.0002690
Strathdee, S. A., Lozada, R., Pollini, R. A., Brouwer, K. C., Mantsios, A., Abramovitz, D. A., ... Patterson, T. L. (2008). Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. Journal of Acquired Immune Deficiency Syndromes, 47(3), 369-376. doi: 10.1097/QAI.0b013e318160d5ae
Vickerman, P., Hickman, M., Rhodes, T., & Watts, C. (2006). Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. JAIDS Journal of Acquired Immune Deficiency Syndromes, 42(3), 355-361. doi: 10.1097/01.qai.0000219788.73539.47
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002). Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics, 27(4), 299-309. doi: 10.1046/j.1365-2710.2002.00430.x
White, E. F., Garfein, R. S., Brouwer, K. C., Lozada, R., Ramos, R., Firestone-Cruz, M., ... Strathdee, S. A. (2007). Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the US. Salud Pública de México, 49(3), 165-172. doi: 10.1590/S0036-36342007000300001
WHO, UNODC, & UNAIDS. (2013). WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users – 2012 revision. WHO, ISBN: 978 92 4 150437 9
Wiessing, L., Ferri, M., Běláčková, V., Carrieri, P., Friedman, S. R., Folch, C., ... Griffiths, P. (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: A consensus study. Harm Reduction Journal, 14(1), 19. doi: 10.1186/s12954-017-0141-6
